Ogkologos | Ogkologos.com | Page 13

Home Authors Posts by Ogkologos

4396 POSTS 0 COMMENTS

Ovarian Function Suppression Plus Tamoxifen Significantly Reduces Premenopausal Breast Cancer Recurrence...

Ogkologos - July 6, 2026

Blood Test May Help Identify Which Colorectal Cancer Patients with Liver...

Ogkologos - July 3, 2026

EMA Recommends Extension of Therapeutic Indications for Encorafenib

Ogkologos - July 3, 2026

New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer

Ogkologos - July 2, 2026

Record Impact Factor for Annals of Oncology Highlights Growing Influence of...

Ogkologos - July 2, 2026

Talquetamab Plus Daratumumab and Pomalidomide and Talquetamab Plus Daratumumab Prolong PFS...

Ogkologos - July 2, 2026

FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy

Ogkologos - July 1, 2026

Neoadjuvant Serplulimab with S-1 Plus Oxaliplatin Followed by Adjuvant Serplulimab Significantly...

Ogkologos - June 30, 2026

Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in...

Ogkologos - June 30, 2026

High HPV Vaccination Coverage in England Associated with a Substantial Reduction...

Ogkologos - June 25, 2026

1...121314...440 Page 13 of 440

MOST POPULAR

Themes in Improving Supportive Care for People With Cancer: 2022 MASCC...

September 1, 2022

Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic...

May 14, 2026

Qué saber sobre los diferentes tipos de mastectomías para el cáncer...

November 15, 2023

Addressing the Barriers to Minority Participation in Cancer Clinical Trials

December 21, 2021

HOT NEWS

Cancer in My Community: Improving Access to Palliative Care in Indonesia

EMA Recommends Extension of Indications for Idecabtagene Vicleucel

Favourable Long-Term Outcomes in Stage II/III TNBC With Atezolizumab Added to Chemotherapy,...

Breast Cancer Survivor Shares Inspiring Images Of Herself As “Bold Indian...